Life sciences news
-
Rewind Therapeutics appoints biopharmaceutical industry veteran Kees Been as Non-Executive Director
Wednesday September 2nd 2020
Read more
-
FOx Biosystems appoints new CEO
Tuesday September 1st 2020
Read more
-
Biocartis expands collaboration with LifeArc
Tuesday September 1st 2020
Read more
-
Oxurion NV reports first patient dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)
Tuesday September 1st 2020
Read more
-
V-Bio Ventures invests in Biodol Therapeutics
Monday August 31st 2020
Read more
-
Newton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases
Thursday August 27th 2020
Read more
-
Vlaanderen investeert ruim kwart miljoen euro in Belgische Google van de genetica
Wednesday August 26th 2020
Read more
-
Persomed appoints Kristof Vercruysse as CEO to drive personalized cancer vaccine venture’s successful implementation
Monday August 24th 2020
Read more
-
Become a flanders.bio member
Your news here?
-
Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severely active rheumatoid arthritis
Wednesday August 19th 2020
Read more
-
Mithra announces commercial launch of Myring™ in the Netherlands
Wednesday August 19th 2020
Read more
-
BioLizard awarded €300,000 VLAIO research grant to establish causal link between the microbiome and disease
Monday August 17th 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
